Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Spinal Cord Neoplasms 1Pituitary Neoplasms 1Parkinson Disease 1Nervous System Diseases 1Epilepsy 1Brain Neoplasms 1

Interventions

Specimen Handling 115Magnetic Resonance Spectroscopy 77Biopsy 69Cyclophosphamide 24pembrolizumab 22Cisplatin 21fludarabine 18Platinum 171,2-diaminocyclohexaneplatinum II citrate 17Taxes 16Paclitaxel 16Carboplatin 16Nivolumab 15Immunoglobulin G 14Disulfides 14X-Rays 13Radiation 13Doxorubicin 12venetoclax 11Radiotherapy 11Gemcitabine 11durvalumab 9cabozantinib 8aldesleukin 8Prednisone 8atezolizumab 7Cytarabine 7olaparib 6lutetium Lu 177 dotatate 6gallium Ga 68 dotatate 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × NIH × Clinical Laboratory Techniques × Clear all
NCT00060541 2026-06-01

Evaluation and Treatment of Neurosurgical Disorders

National Institutes of Health Clinical Center (CC)

Recruiting
5,000 enrolled
CNSEndocrine

Brain Neoplasms, Epilepsy, Nervous System Diseases, Parkinson Disease, Pituitary Neoplasms, Spinal Cord Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡